Compounds > deferoxamine

deferoxamine and adrenomedullin

deferoxamine has been researched along with adrenomedullin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
An, WG; Cuttitta, F; Garayoa, M; Gassmann, M; Johnson, R; Lee, S; Martínez, A; Montuenga, LM; Neckers, L; Pío, R; Ryan, H; Trepel, J1
Hida, W; Kitamuro, T; Murakami, O; Nakayama, M; Shibahara, S; Shirato, K; Takahashi, K; Totsune, K1
Chilvers, ER; Cowburn, AS; Deighton, J; Greening, AP; Mecklenburgh, KI; Reed, BJ; Upton, PD; Walmsley, SR; Wiesener, M1
Aguilar-Quesada, R; Martínez-Lara, E; Martínez-Romero, R; Oliver, FJ; Peralta, A; Siles, E1
Gidday, JM; Zhang, L; Zhu, Y1

Other Studies

5 other study(ies) available for deferoxamine and adrenomedullin

ArticleYear
Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis.
    Molecular endocrinology (Baltimore, Md.), 2000, Volume: 14, Issue:6

    Topics: Adrenomedullin; Cell Hypoxia; Culture Media, Conditioned; Deferoxamine; DNA; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Luciferases; Neoplasms; Nuclear Proteins; Oxygen; Peptides; Promoter Regions, Genetic; Response Elements; RNA, Messenger; Transcription Factors; Tumor Cells, Cultured

2000
Differential expression of adrenomedullin and its receptor component, receptor activity modifying protein (RAMP) 2 during hypoxia in cultured human neuroblastoma cells.
    Peptides, 2001, Volume: 22, Issue:11

    Topics: Adrenomedullin; Antimutagenic Agents; Cell Hypoxia; Cobalt; Deferoxamine; Gene Expression; Humans; Intracellular Signaling Peptides and Proteins; Iron Chelating Agents; Membrane Proteins; Neuroblastoma; Peptides; Receptor Activity-Modifying Protein 2; Receptor Activity-Modifying Proteins; Receptors, Adrenomedullin; Receptors, Peptide; Tumor Cells, Cultured

2001
Involvement of a ferroprotein sensor in hypoxia-mediated inhibition of neutrophil apoptosis.
    Blood, 2002, Oct-15, Volume: 100, Issue:8

    Topics: Adrenomedullin; Apoptosis; Base Sequence; Cell Hypoxia; Cells, Cultured; Deferoxamine; DNA Primers; Glucose; Humans; Interleukin-8; Iron Chelating Agents; Mitochondria; Neutrophils; Peptides; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic

2002
PARP-1 modulates deferoxamine-induced HIF-1alpha accumulation through the regulation of nitric oxide and oxidative stress.
    Journal of cellular biochemistry, 2008, Aug-15, Volume: 104, Issue:6

    Topics: Adrenomedullin; Animals; Antioxidants; Blotting, Western; Deferoxamine; Gene Expression Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Microscopy, Confocal; Models, Biological; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Reactive Oxygen Species; RNA, Messenger; Superoxide Dismutase; Thermodynamics; Time Factors

2008
Deferroxamine preconditioning promotes long-lasting retinal ischemic tolerance.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2008, Volume: 24, Issue:6

    Topics: Adrenomedullin; Animals; Deferoxamine; Dose-Response Relationship, Drug; Hypoxia-Inducible Factor 1, alpha Subunit; Iron Chelating Agents; Ischemia; Ischemic Preconditioning; Male; Mice; Retinal Vessels

2008